Ausgabe 2/2019
Inhalt (15 Artikel)
New horizons in breast cancer: the promise of immunotherapy
L. de la Cruz-Merino, N. Palazón-Carrión, F. Henao-Carrasco, E. Nogales-Fernández, M. Álamo-de la Gala, A. Vallejo-Benítez, M. Chiesa, V. Sánchez-Margalet
The microRNA signatures: aberrantly expressed miRNAs in prostate cancer
N. Sharma, M. M. Baruah
Molecular biomarkers for prognosis of gastrointestinal stromal tumor
X. Liu, K.-M. Chu
Tumor-derived exosomes in cancer metastasis risk diagnosis and metastasis therapy
S. Jiang, C. Hu, P. Liu, M. Lu
Do locally advanced and metastatic human epithelial cancers evolve in ‘placental/decidual-like microenvironments’?
M. Hernández-Bronchud
CalliSpheres® drug-eluting beads (DEB) transarterial chemoembolization (TACE) is equally efficient and safe in liver cancer patients with different times of previous conventional TACE treatments: a result from CTILC study
X. Zhang, J. Zhou, D.-D. Zhu, J. Huang, J.-H. Sun, T.-F. Li, C.-S. Shi, Z.-C. Sun, Q.-M. Hou, Z.-Y. Peng, W.-Q. Yu, J.-S. Ji, W.-J. Gu, G.-H. Zhou, X.-X Xie, X.-H. Guo, G.-H. Cao, Z.-H. Yu, H.-H. Xu, J. Fang, S.-H. Ying, W.-H. Hu, W.-B. Ji, J. Han, X. Wu, J.-P. Zheng, J. Luo, Y.-T. Chen, T.-Y. Hu, L. Li, H.-J. Hu, H.-J. Du, G.-L. Shao
Inter-observer variation of hippocampus delineation in hippocampal avoidance prophylactic cranial irradiation
F. Bartel, M. van Herk, H. Vrenken, F. Vandaele, S. Sunaert, K. de Jaeger, N. J. Dollekamp, C. Carbaat, E. Lamers, E. M. T. Dieleman, Y. Lievens, D. de Ruysscher, S. B. Schagen, M. B. de Ruiter, J. C. de Munck, J. Belderbos
Bloodstream infection in patients with head and neck cancer: a major challenge in the cetuximab era
M. Marín, C. Gudiol, F. Castet, M. Oliva, I. Peiró, C. Royo-Cebrecos, J. Carratalà, R. Mesia
Differential molecular markers of primary lung tumors and metastatic sites indicate different possible treatment selections in patients with metastatic lung adenocarcinoma
L.-L. Deng, H.-B. Deng, C.-L. Lu, G. Gao, F. Wang, Y. Yang
The absolute lymphocyte count can predict the overall survival of patients with non-small cell lung cancer on nivolumab: a clinical study
T. Karantanos, S. Karanika, B. Seth, G. Gignac
The value of radical radiotherapy in the primary tumor of newly diagnosed oligo-metastatic nasopharyngeal carcinoma patients
H. Shuang, J. Feng, C. Caineng, J. Qifeng, J. Tin, C. Yuanyuan, C. Xiaozhong
iTRAQ-based proteomic analysis of DMH-induced colorectal cancer in mice reveals the expressions of β-catenin, decorin, septin-7, and S100A10 expression in 53 cases of human hereditary polyposis colorectal cancer
G. Liu, F. Fei, J. Qu, X. Wang, Y. Zhao, Y. Li, S. Zhang
Prognostic analysis of stage III gastric cancer after curative surgery according to the newest TNM classification
J. Wei, T. Yao, Y. Wang, L. Li, C. Pan, N. Zhang
Controversies in the management of stage I seminoma: adjuvant carboplatin revisited
J. Aparicio, J. Terrasa